Quick Answer
ORAGENICS INC reported Cash and Equivalents of $4.40 million for fiscal year 2025.
ORAGENICS INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $4.40M | +408.7% |
| 2024 | $864.8K | -75.2% |
| 2023 | $3.48M | -69.5% |
| 2022 | $11.43M | -58.1% |
| 2021 | $27.27M | +54.6% |
| 2020 | $17.64M | -3.4% |
| 2019 | $18.27M | -9.6% |
| 2018 | $20.21M | +227.7% |
| 2017 | $6.17M | +51.1% |
| 2016 | $4.08M | -19.7% |
| 2015 | $5.08M | -51.4% |
| 2014 | $10.45M | -35.8% |
| 2013 | $16.28M | +64.0% |
| 2012 | $9.93M | +5679.7% |
| 2011 | $171.7K | +30.0% |
| 2010 | $132.1K | -56.2% |
| 2009 | $301.6K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.40M | +262.7% | +477.8% |
| June 30, 2025 | $1.97M | +46.4% | -42.3% |
| March 31, 2025 | $3.42M | +65.1% | +295.6% |
| December 31, 2024 | $864.8K | -75.2% | -72.5% |
| September 30, 2024 | $3.14M | -45.5% | +133.1% |
| June 30, 2024 | $1.35M | -79.2% | -34.9% |
| March 31, 2024 | $2.07M | -77.4% | -40.5% |
| December 31, 2023 | $3.48M | -69.5% | -39.6% |
- ORAGENICS INC showed an increase of +408.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, ORAGENICS INC’s cash and equivalents has grown by 1358.8% (from $301.6 thousand to $4.40 million).
- The most recent figure is from ORAGENICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: